Biotechnology startup Fermentech GSV, spearheaded by founders GR Gopi and P Sathyavrathan, has announced plans to expand its biomanufacturing and biofoundry capabilities in Thanjavur, Tamil Nadu. The expansion is propelled by funding from the Biotechnology Industry Research Assistance Council (BIRAC).
Startups in the industrial biotechnology sector are increasingly focusing on the sustainable production of biologicals and biochemicals for the agricultural and food sectors, alongside essential enzymes used in pharmaceutical drug synthesis. To address a critical industry bottleneck, Fermentech GSV is establishing piloting and pre-commercial infrastructure at the site.
This new facility is designed to enable the company to scale biotech products and co-develop manufacturing processes alongside partner startups. By bridging the persistent gap in early- and mid-stage infrastructure required for product scale-up and production, the initiative is expected to support broader sector investments.
With the new infrastructure operational, venture capital-funded startups will gain access to resources needed to scale sustainable innovations. Applications expected to be supported at the facility include bioplastics, sugar alternatives such as brazzein, smart proteins like microbial casein analogs, biocolors, marine biology-inspired chemicals, agrochemical inputs, and pharmaceutical biocatalysts.
The augmentation of Fermentech GSV's piloting facility is supported by the Bio-Enabler scheme of the Department of Biotechnology and BIRAC. According to the company, this development aligns with the Union government's BioE3 (Biotechnology for Economy, Environment and Employment) policy mission, which aims to encourage a nationwide shift toward sustainable and high-performance biomanufacturing models.
"The expansion of biomanufacturing and biofoundry infrastructure by Fermentech GSV highlights a vital step toward solving early-stage scale-up bottlenecks for biotechnology startups in India. By providing piloting and pre-commercial facilities with support from BIRAC, the company is addressing a critical gap that often hinders hardware and biotech ventures from reaching commercial viability. This initiative not only aids product co-development but also strengthens the broader ecosystem by aligning with national sustainability goals under the BioE3 policy." — Dr. Shishir Gupta, Founder & CEO, StartupLanes
Recent StartupLanes Articles
Browse through our 30 latest publications on venture capital, startups, and angel investing.